IPR Tracker: IPR2015-01514 and IPR2015-01517 (Amgen Inc.) (U.S. Patent Nos. 8,916,157 and 8,916,158)

IPR2015-01514 (Amgen Inc.) (U.S. Patent No. 8,916,157)

• Petitioner: Amgen Inc.
• Patent: U.S. Patent No. 8,916,157
• Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
• Patent Owner: AbbVie Biotechnology Ltd.

IPR2015-01517 (Amgen Inc.) (U.S. Patent No. 8,916,158)

• Petitioner: Amgen Inc.
• Patent: U.S. Patent No. 8,916,158
• Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
• Patent Owner: AbbVie Biotechnology Ltd.

The post IPR Tracker: IPR2015-01514 and IPR2015-01517 (Amgen Inc.) (U.S. Patent Nos. 8,916,157 and 8,916,158) appeared first on Big Molecule Watch.